113. New Developments in Invasive Fungal Infections
Friday, October 9, 2015: 8:30 AM-10:00 AM
Room: 31--ABC
Co-organized with IDSA Immunocompromised Host Working Group and the Immunocompromised Host Society (ICHS)

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • critically appraise the genetic factors predisposing to fungal infection
  • discuss novel fungal diagnostic approaches
  • describe new development in the management of invasive fungal disease

Target Audience: Scientists, Researchers, Pharmacists, Microbiologists, Members-in-training, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, HIV specialists, HIV clinicians, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Pediatric ID, Investigative ID, HIV-STD-TB, Adult ID, Trainee

Moderators:  Thomas Patterson, MD, FIDSA, The University of Texas Health Science Center and Kimberly Hanson, MD, MHS, University of Utah School of Medicine

8:30 AM
Host Genetics and Susceptibility to Fungal Infections
Pierre-Yves Bochud, Privat Docent MD

9:00 AM
New Fungal Diagnostics
Sophia Koo, MD

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-172-L01-P


T. Patterson, Astellas: Scientific Advisor , Consulting fee
Merck: Scientific Advisor , Consulting fee
Toyama: Scientific Advisor , Consulting fee
Pfizer: Consultant , Speaker honorarium
Revolution Medicines: Consultant , Consulting fee

K. Hanson, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.